A recombinant peptide antigen line immunoassay optimized for the confirmation of Chagas' disease
- 1 July 1999
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 39 (7), 711-717
- https://doi.org/10.1046/j.1537-2995.1999.39070711.x
Abstract
BACKGROUND: The transfusion of contaminated blood has become the major route of transmission for Chagas' disease in Brazil. Current screening tests are insensitive and yield conflicting results, while confirmatory assays do not exist. A line immunoassay (INNO‐LIA Chagas Ab [INNO‐LIA]) combining relevant, immunodominant recombinant and synthetic antigens on a single nylon membrane strip was evaluated for the serologic confirmation of Chagas' disease. STUDY DESIGN AND METHODS: Sera from 1062 patients and healthy residents of four Brazilian regions endemic for Chagas' disease were used for test optimization. The established confirmation algorithm was evaluated with an independent set of positive (n = 75) and negative (n = 148) samples. RESULTS: In the optimization phase, without an established comparative gold standard, the results with the INNO‐LIA were compared with those obtained in four other screening assays. In the validation phase, the INNO‐LIA showed a sensitivity of 100 percent (95% CI, 95.21‐100) and a specificity of 99.32 percent (95% CI, 96.29‐99.98) for well‐characterized sera. Moreover, its specificity reached 100 percent with a set of 40 sera obtained from patients with documented leishmaniasis. The interpretation criteria defined in this study indicated that the INNO‐LIA accurately detected the presence of antibodies to various specific antigens of Trypanosoma cruzi. CONCLUSION: The INNO‐LIA Chagas Ab assay may become the first commercial assay to reliably confirm the presence of antibodies to T. cruzi.Keywords
This publication has 37 references indexed in Scilit:
- Chagas' disease in the Brazilian Amazon: III. a cross-sectional sutdyRevista do Instituto de Medicina Tropical de São Paulo, 1995
- Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. II. Evaluation of a supplemental enzyme immunoassay and radioimmunoprecipitation assay for confirmation of seroreactivityTransfusion, 1995
- An urban outbreak of visceral leishmaniasis in Natal, BrazilTransactions of the Royal Society of Tropical Medicine and Hygiene, 1994
- Detection of antibodies in sera from Chagas' disease patients using a Trypanosoma cruzi immunodominant recombinant antigenParasite Immunology, 1994
- RecombinantTrypanosoma cruziantigens and Chagas' disease diagnosis: analysis of a workshopFEMS Microbiology Letters, 1991
- Use of two recombinant proteins of Trypanosoma cruzi in the serological diagnosis of Chagas diseaseMemórias do Instituto Oswaldo Cruz, 1990
- Use of recombinant antigens for the diagnosis of Chagas disease and blood bank screeningMemórias do Instituto Oswaldo Cruz, 1990
- Structure and expression of two Trypanosoma cruzi genes encoding antigenic proteins bearing repetitive epitopesMolecular and Biochemical Parasitology, 1989
- Identification of a Trypanosoma cruzi antigen that is shed during the acute phase of Chagas' diseaseMolecular and Biochemical Parasitology, 1989
- Morbidade da doença de Chagas. II. Estudos seccionais em quatro áreas de campo no BrasilMemórias do Instituto Oswaldo Cruz, 1984